Amarin Corp Plcuk (AMRN) Assets Growth (1y) (2011 - 2026)

Amarin Corp Plcuk (AMRN) Assets Growth (1y) (2011 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.52%
Dec 31, 2025 -2.13%
Sep 30, 2025 -12.10%
Jun 30, 2025 -16.22%
Mar 31, 2025 -17.00%
Dec 31, 2024 -17.60%
Sep 30, 2024 -10.54%
Jun 30, 2024 -6.99%
Mar 31, 2024 -8.16%
Dec 31, 2023 -6.15%
Sep 30, 2023 -7.63%
Jun 30, 2023 -11.63%
Mar 31, 2023 -11.66%
Dec 31, 2022 -17.03%
Sep 30, 2022 -12.31%
Jun 30, 2022 -6.87%
Mar 31, 2022 -1.68%
Dec 31, 2021 10.56%
Sep 30, 2021 7.87%
Jun 30, 2021 14.22%